JW Lifescience Corporation (KRX:234080)
South Korea · Delayed Price · Currency is KRW 11,000
-20 (-0.18%)
Sep 11, 2026, 3:30 PM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 170.33 billion as of September 11, 2026. Its market cap has decreased by -8.18% in one year.
Market Cap
170.33B
Enterprise Value
190.62B
Revenue
253.71B
Ranking
n/a
PE Ratio
6.55
Stock Price
11,000.00
ChartMarket Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 170.33B, a decrease of -49.91%. That is a compound annual growth rate of -6.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 170.33B | -14.40% |
| Dec 30, 2025 | 198.98B | 18.11% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yungjin Pharm. | 196.24B |
| Whan In Pharm | 190.94B |
| BNC KOREA | 186.72B |
| Chong Kun Dang Holdings | 185.66B |
| REYON Pharmaceutical | 185.06B |
| AptaBio Therapeutics | 178.39B |
| FutureChem Co.,Ltd | 175.57B |
| Daewon Pharmaceutical | 170.82B |